Effect of green tea supplements on liver enzyme elevation: Results from a randomized intervention study in the United States

Zheming Yu, Hamed Samavat, Allison M. Dostal, Renwei Wang, Carolyn J. Torkelson, Chung S. Yang, Lesley M. Butler, Thomas W. Kensler, Anna H. Wu, Mindy S. Kurzer, Jian Min Yuan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Liver injury effects of green tea–based products have been reported in sporadic case reports. However, no study has examined systematically such adverse effects in an unbiased manner. We examined the potential effects of a high, sustained oral dose of green tea extract (GTE) on liver injury measures in a randomized, placebo-controlled, double-blinded phase II clinical trial, which enrolled 1,075 women with the original aim to assess the effect of daily GTE consumption for 12 months on biomarkers of breast cancer risk. The current analysis examined the effect of GTE consumption on liver injury in 1,021 participants (513 in GTE and 508 in placebo arm) with normal baseline levels of liver enzymes. Among women in the GTE arm, alanine aminotransferase (ALT) increased by 5.4 U/L [95% confidence interval (CI), 3.6–7.1] and aspartate aminotransferase increased by 3.8 U/L (95% CI, 2.5–5.1), which were significantly higher than those among women in the placebo arm (both P < 0.001). Overall, 26 (5.1%) women in GTE developed moderate or more severe abnormalities in any liver function measure during the intervention period, yielding an OR of 7.0 (95% CI, 2.4–20.3) for developing liver function abnormalities as compared with those in the placebo arm. ALT returned to normal after dechallenge and increased again after one or more rechallenges with GTE. The rise–fall pattern of liver enzyme values following the challenge–dechallenge cycles of GTE consumption strongly implicates the effect of high-dose GTE on liver enzyme elevations.

Original languageEnglish (US)
Pages (from-to)571-579
Number of pages9
JournalCancer Prevention Research
Volume10
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Tea
Liver
Enzymes
Placebos
Liver Extracts
Confidence Intervals
Alanine Transaminase
Wounds and Injuries
Phase II Clinical Trials
Aspartate Aminotransferases
Biomarkers
Breast Neoplasms

Cite this

Effect of green tea supplements on liver enzyme elevation : Results from a randomized intervention study in the United States. / Yu, Zheming; Samavat, Hamed; Dostal, Allison M.; Wang, Renwei; Torkelson, Carolyn J.; Yang, Chung S.; Butler, Lesley M.; Kensler, Thomas W.; Wu, Anna H.; Kurzer, Mindy S.; Yuan, Jian Min.

In: Cancer Prevention Research, Vol. 10, No. 10, 01.10.2017, p. 571-579.

Research output: Contribution to journalArticle

Yu, Zheming ; Samavat, Hamed ; Dostal, Allison M. ; Wang, Renwei ; Torkelson, Carolyn J. ; Yang, Chung S. ; Butler, Lesley M. ; Kensler, Thomas W. ; Wu, Anna H. ; Kurzer, Mindy S. ; Yuan, Jian Min. / Effect of green tea supplements on liver enzyme elevation : Results from a randomized intervention study in the United States. In: Cancer Prevention Research. 2017 ; Vol. 10, No. 10. pp. 571-579.
@article{2a167d62a4474bb6ad4c1de0804df61b,
title = "Effect of green tea supplements on liver enzyme elevation: Results from a randomized intervention study in the United States",
abstract = "Liver injury effects of green tea–based products have been reported in sporadic case reports. However, no study has examined systematically such adverse effects in an unbiased manner. We examined the potential effects of a high, sustained oral dose of green tea extract (GTE) on liver injury measures in a randomized, placebo-controlled, double-blinded phase II clinical trial, which enrolled 1,075 women with the original aim to assess the effect of daily GTE consumption for 12 months on biomarkers of breast cancer risk. The current analysis examined the effect of GTE consumption on liver injury in 1,021 participants (513 in GTE and 508 in placebo arm) with normal baseline levels of liver enzymes. Among women in the GTE arm, alanine aminotransferase (ALT) increased by 5.4 U/L [95{\%} confidence interval (CI), 3.6–7.1] and aspartate aminotransferase increased by 3.8 U/L (95{\%} CI, 2.5–5.1), which were significantly higher than those among women in the placebo arm (both P < 0.001). Overall, 26 (5.1{\%}) women in GTE developed moderate or more severe abnormalities in any liver function measure during the intervention period, yielding an OR of 7.0 (95{\%} CI, 2.4–20.3) for developing liver function abnormalities as compared with those in the placebo arm. ALT returned to normal after dechallenge and increased again after one or more rechallenges with GTE. The rise–fall pattern of liver enzyme values following the challenge–dechallenge cycles of GTE consumption strongly implicates the effect of high-dose GTE on liver enzyme elevations.",
author = "Zheming Yu and Hamed Samavat and Dostal, {Allison M.} and Renwei Wang and Torkelson, {Carolyn J.} and Yang, {Chung S.} and Butler, {Lesley M.} and Kensler, {Thomas W.} and Wu, {Anna H.} and Kurzer, {Mindy S.} and Yuan, {Jian Min}",
year = "2017",
month = "10",
day = "1",
doi = "10.1158/1940-6207.CAPR-17-0160",
language = "English (US)",
volume = "10",
pages = "571--579",
journal = "Cancer Prevention Research",
issn = "1940-6207",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Effect of green tea supplements on liver enzyme elevation

T2 - Results from a randomized intervention study in the United States

AU - Yu, Zheming

AU - Samavat, Hamed

AU - Dostal, Allison M.

AU - Wang, Renwei

AU - Torkelson, Carolyn J.

AU - Yang, Chung S.

AU - Butler, Lesley M.

AU - Kensler, Thomas W.

AU - Wu, Anna H.

AU - Kurzer, Mindy S.

AU - Yuan, Jian Min

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Liver injury effects of green tea–based products have been reported in sporadic case reports. However, no study has examined systematically such adverse effects in an unbiased manner. We examined the potential effects of a high, sustained oral dose of green tea extract (GTE) on liver injury measures in a randomized, placebo-controlled, double-blinded phase II clinical trial, which enrolled 1,075 women with the original aim to assess the effect of daily GTE consumption for 12 months on biomarkers of breast cancer risk. The current analysis examined the effect of GTE consumption on liver injury in 1,021 participants (513 in GTE and 508 in placebo arm) with normal baseline levels of liver enzymes. Among women in the GTE arm, alanine aminotransferase (ALT) increased by 5.4 U/L [95% confidence interval (CI), 3.6–7.1] and aspartate aminotransferase increased by 3.8 U/L (95% CI, 2.5–5.1), which were significantly higher than those among women in the placebo arm (both P < 0.001). Overall, 26 (5.1%) women in GTE developed moderate or more severe abnormalities in any liver function measure during the intervention period, yielding an OR of 7.0 (95% CI, 2.4–20.3) for developing liver function abnormalities as compared with those in the placebo arm. ALT returned to normal after dechallenge and increased again after one or more rechallenges with GTE. The rise–fall pattern of liver enzyme values following the challenge–dechallenge cycles of GTE consumption strongly implicates the effect of high-dose GTE on liver enzyme elevations.

AB - Liver injury effects of green tea–based products have been reported in sporadic case reports. However, no study has examined systematically such adverse effects in an unbiased manner. We examined the potential effects of a high, sustained oral dose of green tea extract (GTE) on liver injury measures in a randomized, placebo-controlled, double-blinded phase II clinical trial, which enrolled 1,075 women with the original aim to assess the effect of daily GTE consumption for 12 months on biomarkers of breast cancer risk. The current analysis examined the effect of GTE consumption on liver injury in 1,021 participants (513 in GTE and 508 in placebo arm) with normal baseline levels of liver enzymes. Among women in the GTE arm, alanine aminotransferase (ALT) increased by 5.4 U/L [95% confidence interval (CI), 3.6–7.1] and aspartate aminotransferase increased by 3.8 U/L (95% CI, 2.5–5.1), which were significantly higher than those among women in the placebo arm (both P < 0.001). Overall, 26 (5.1%) women in GTE developed moderate or more severe abnormalities in any liver function measure during the intervention period, yielding an OR of 7.0 (95% CI, 2.4–20.3) for developing liver function abnormalities as compared with those in the placebo arm. ALT returned to normal after dechallenge and increased again after one or more rechallenges with GTE. The rise–fall pattern of liver enzyme values following the challenge–dechallenge cycles of GTE consumption strongly implicates the effect of high-dose GTE on liver enzyme elevations.

UR - http://www.scopus.com/inward/record.url?scp=85030676469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030676469&partnerID=8YFLogxK

U2 - 10.1158/1940-6207.CAPR-17-0160

DO - 10.1158/1940-6207.CAPR-17-0160

M3 - Article

C2 - 28765194

AN - SCOPUS:85030676469

VL - 10

SP - 571

EP - 579

JO - Cancer Prevention Research

JF - Cancer Prevention Research

SN - 1940-6207

IS - 10

ER -